We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Science Group Plc | LSE:SAG | London | Ordinary Share | GB00B39GTJ17 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 415.00 | 410.00 | 420.00 | 415.00 | 415.00 | 415.00 | 10,950 | 07:43:20 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Business Consulting Svcs,nec | 98.82M | 10.56M | 0.2322 | 17.87 | 188.65M |
From Apr 2019 to Apr 2024
TIDMSAG
RNS Number : 7067G
Science Group PLC
19 March 2020
19 March 2020
Science Group plc
(the "Company" or "Science Group")
Transaction in own shares
Science Group plc (AIM:SAG) announces that, on 18 March 2020, it purchased 5,000 of its 1 pence ordinary shares at an average price of 180.0 pence per share. The highest price paid per share was 180.0 pence and the lowest price paid per share was 180.0 pence. The Company purchased these shares through Liberum Capital Limited.
The number of shares purchased represented 0.01% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.
The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 41,695,440. Science Group holds 366,595 shares in treasury. The total number of voting rights in the Company following this announcement is 41,591,040.
The figure of 41,591,040 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Liberum Capital Limited on behalf of the Company as part of the buyback programme.
Number of shares purchased Transaction price (per share) Time of transaction Execution venue 5000 180.0 16:32:38 AIMX
- Ends -
For further information:
Hot Features
Premium
Science Group plc
Sarah Cole, Company Secretary Tel: +44 (0) 1223 875
200
Panmure Gordon (UK) Limited
Nominated Adviser: Dominic Morley/Alina Tel: +44 (0) 20 7886
Vaskina 2500
Corporate Broking: Erik Anderson
Liberum Capital Limited Tel: +44 (0) 20 3100
2000
Neil Patel/Cameron Duncan/Robert Morton/Ed
Phillips
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
POSKKFBDFBKDFND
(END) Dow Jones Newswires
March 19, 2020 03:00 ET (07:00 GMT)
1 Year Science Chart |
1 Month Science Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
